Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders
US11597726B2 · kind B2 · utility
0Cited by
11References
54Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 2021 |
| Grant date | Mar 7, 2023 |
| Priority date | — |
| Expiry date | Jun 24, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Ring deuterated gaboxadol is provided. The ring deuterated gaboxadol is useful in the treatment of psychiatric disorders and is more effective than non-deuterated gaboxadol in such treatments. Deuterated gaboxadol is useful in combinations with other compounds to provide additive and synergistic effects for patient therapies. In a specific embodiment, the deuterated gaboxadol is d6-gaboxadol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.